Martha Neagu

Martha Neagu

Company: AbbVie

Job title: Associate Medical Director


Panel Discussion: Predicting Future Directions for NSCLC Therapeutic Development and Treatment 4:00 pm

How will future combinations, or novel therapeutic design (bispecifics etc), address acquired resistance to TKI treatments and improve patient outcomes? How will new, fast and accurate diagnostic technologies enable appropriate patient selection for future clinical investigations and increase the clinical utility of new approved therapies? What is on the horizon for targeted therapies for uncommon…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.